U.S. Markets closed
  • S&P 500

    4,513.04
    -53.96 (-1.18%)
     
  • Dow 30

    34,022.04
    -461.68 (-1.34%)
     
  • Nasdaq

    15,254.05
    -283.64 (-1.83%)
     
  • Russell 2000

    2,147.42
    -51.49 (-2.34%)
     
  • Crude Oil

    65.71
    +0.14 (+0.21%)
     
  • Gold

    1,783.10
    -1.20 (-0.07%)
     
  • Silver

    22.32
    -0.02 (-0.11%)
     
  • EUR/USD

    1.1322
    -0.0017 (-0.1472%)
     
  • 10-Yr Bond

    1.4340
    -0.0090 (-0.62%)
     
  • Vix

    31.12
    +3.93 (+14.45%)
     
  • GBP/USD

    1.3281
    -0.0020 (-0.1527%)
     
  • USD/JPY

    112.8500
    -0.3300 (-0.2916%)
     
  • BTC-USD

    57,125.03
    -249.56 (-0.43%)
     
  • CMC Crypto 200

    1,442.71
    -26.37 (-1.79%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

Why Shares of Avadel Are Sinking Today

·2 min read
Why Shares of Avadel Are Sinking Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Avadel Pharmaceuticals (NASDAQ: AVDL) are down 14% as of 1:29 p.m. EDT today after the Food and Drug Administration said it would need more time than originally thought to review FT218 -- Avadel's candidate to treat narcolepsy. After accepting a company's approval filing, the FDA provides applicants with a date known as the Prescription Drug User Fee Amendments date -- or PDUFA date. In some instances -- like that of Avadel's FT218 -- the agency misses its target.